Sources Sought Notice - Risk–Benefit Assessment of Stopping Antibiotics in Rapid Respiratory Viral Panel (RVP) Positive Inpatients with Non-Severe Community-Acquired Pneumonia
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
OMAS STRATEGIC BUYING CENTER - HHS MISSION
Contract Value
Not provided
Codes & Classification
Solicitation Number
HHS-AHRQ-SS-26-10002
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Classification Code
AN12
Additional Details
The Department of Health and Human Services (HHS), through the Office of the Assistant Secretary for Financial Resources (ASFR) and the OMAS Strategic Buying Center, has issued a Sources Sought notice (Procurement Identifier: HHS-AHRQ-SS-26-10002) to assess the availability and capabilities of qualified organizations for a forthcoming research initiative. This notice is not a solicitation for proposals but rather a market research tool to identify potential sources, including small and disadvantaged businesses, capable of conducting a large-scale, pragmatic randomized controlled trial (RCT) focused on antibiotic stewardship in the management of non-severe community-acquired pneumonia (CAP) among inpatients who test positive for respiratory viral pathogens.
**Purpose and Scope**
The primary objective of this procurement is to rigorously evaluate the risks and benefits associated with the continuation versus discontinuation of antibacterial therapy in hospitalized adults (aged 18 and older) with non-severe CAP who are confirmed positive for at least one viral pathogen via multiplex respiratory viral panel (RVP). The impetus for this research stems from the high prevalence of unnecessary antibiotic use in this patient population, which not only fails to confer clinical benefit but also exposes patients to potential harm, increases healthcare costs, and contributes to the broader public health crisis of antimicrobial resistance.
The study aims to address the lack of consensus in current clinical guidelines regarding antibiotic use in viral pneumonia, as highlighted by recent divergent recommendations from the American Thoracic Society and the Infectious Diseases Society of America. By generating robust evidence through a multicenter RCT, the project seeks to inform future clinical guidelines and promote responsible antibiotic prescribing practices.
**Key Requirements and Expected Deliverables**
Contractors responding to this notice must demonstrate the capability to independently provide all necessary personnel, services, materials, equipment, and facilities to fulfill the following core requirements:
1. **Design and Execution of a Pragmatic RCT:** Conduct a randomized controlled trial comparing continued versus discontinued antibacterial therapy in the target patient population, with randomization occurring at the physician order level.
2. **Multicenter Coordination:** Establish and oversee trial sites in at least three geographically distinct health systems, ensuring site primary investigator oversight and robust coordination of research activities.
3. **Patient Recruitment:** Enroll approximately 1,000 adult patients across the participating sites, with strong recruitment strategies and contingency plans.
4. **Clinical Framework Development:** Develop and implement a clinical framework to identify eligible patients who can safely discontinue antibiotics, utilizing clinical, laboratory, and radiologic data.
5. **Outcomes Evaluation:** Assess primary and secondary outcomes, including time to clinical stability, patient safety outcomes, 30-day readmissions, and antibiotic-associated adverse events. Subgroup analyses by viral pathogen and patient characteristics are also required.
6. **Data Management and Security:** Ensure secure data storage and management, including handling of personally identifiable information (PII) and, if necessary, protected health information (PHI).
7. **Dissemination of Findings:** Publish results in peer-reviewed journals and present at scientific conferences to inform clinical practice and stewardship efforts.
8. **Regulatory and Project Management Compliance:** Demonstrate proficiency in federal requirements such as Section 508 accessibility, OMB Paperwork Reduction Act submissions, and Institutional Review Board (IRB) compliance. Develop and execute a comprehensive project management plan detailing organizational structure, roles, communication protocols, and strategies for overcoming challenges.
**Contracting Entity and Classification Details**
- **Contracting Entity:** OMAS Strategic Buying Center - HHS Mission (Office of the Assistant Secretary for Financial Resources)
- **Department:** Health and Human Services, Department of
- **NAICS Code:** 541715 – Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- **Product Service Code:** AN12
- **Location:** Not specified; trial sites must be geographically distinct within the United States.
- **Primary Contact:** Kori Best ([email protected])
**Procurement Type and Special Considerations**
This is a Sources Sought notice intended to inform the government’s acquisition strategy, including the potential for set-aside opportunities for small and disadvantaged businesses. Respondents are encouraged to indicate their business size and type (e.g., 8(a), HUBZone, woman-owned, service-disabled veteran-owned) relative to the NAICS code. No contract will be awarded as a result of this notice; it is strictly for market research and planning purposes.
**Submission Instructions**
Interested organizations should submit a tailored capability statement (maximum 15 single-sided pages, including all attachments) in MS Word or PDF format, detailing their expertise, capacity, relevant experience, and any existing government-wide contracting vehicles. The cover page must include the organization’s UEI number, name, address, business size/type, and technical points of contact. Participation agreement statements from partner organizations are encouraged and may be submitted in addition to the page limit. All responses must be submitted electronically to Kori Best at [email protected] by 3:00 PM EST on April 27, 2026.
**Constant Elements Over Contract Lifecycle**
Throughout the contract lifecycle, the focus will remain on the rigorous conduct of a multicenter pragmatic RCT, adherence to federal regulatory and reporting requirements, secure and compliant data management, and the dissemination of findings to inform national clinical practice. The contractor must maintain robust project management, effective stakeholder communication, and a commitment to advancing antibiotic stewardship in alignment with HHS’s public health mission.
For further details and updates, interested parties should refer to the official notice on SAM.gov (Opportunity ID: ca730ae566c247c3bf1bb1ccbb43267d).
**Notice URL:** [https://sam.gov/opp/ca730ae566c247c3bf1bb1ccbb43267d/view](https://sam.gov/opp/ca730ae566c247c3bf1bb1ccbb43267d)